Suzanne Jurriaans

7.7k total citations
128 papers, 5.6k citations indexed

About

Suzanne Jurriaans is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Suzanne Jurriaans has authored 128 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Virology, 96 papers in Infectious Diseases and 25 papers in Epidemiology. Recurrent topics in Suzanne Jurriaans's work include HIV Research and Treatment (103 papers), HIV/AIDS drug development and treatment (73 papers) and HIV/AIDS Research and Interventions (66 papers). Suzanne Jurriaans is often cited by papers focused on HIV Research and Treatment (103 papers), HIV/AIDS drug development and treatment (73 papers) and HIV/AIDS Research and Interventions (66 papers). Suzanne Jurriaans collaborates with scholars based in Netherlands, United States and United Kingdom. Suzanne Jurriaans's co-authors include Joep M. A. Lange, Jan M. Prins, Gerrit Jan Weverling, Ben Berkhout, Margreet Bakker, Hanneke Schuitemaker, Jaap Goudsmit, Ferdinand W N M Wit, Roel A. Coutinho and Bob van Gemen and has published in prestigious journals such as The Lancet, PLoS ONE and PEDIATRICS.

In The Last Decade

Suzanne Jurriaans

127 papers receiving 5.4k citations

Peers

Countries citing papers authored by Suzanne Jurriaans

Since Specialization

Citations

This map shows the geographic impact of Suzanne Jurriaans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne Jurriaans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne Jurriaans more than expected).

Fields of papers citing papers by Suzanne Jurriaans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne Jurriaans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne Jurriaans. The network helps show where Suzanne Jurriaans may publish in the future.

Co-authorship network of co-authors of Suzanne Jurriaans

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne Jurriaans. A scholar is included among the top collaborators of Suzanne Jurriaans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne Jurriaans. Suzanne Jurriaans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Soluble CD14 and IL-12p70 on early antiretroviral therapy predict HIV load setpoint after treatment interruption 2025 ·AIDS ·(unknown), Anders Boyd, Alexander Pasternak, Irma Maurer, (unknown), Marlous L. Grijsen, Suzanne Jurriaans, Jan M. Prins, Neeltje A. Kootstra, Godelieve J. de Bree	1
2	Intent to vaccinate against SARS-CoV-2 and its determinants across six ethnic groups living in Amsterdam, the Netherlands: A cross-sectional analysis of the HELIUS study 2023 ·Vaccine ·(unknown), (unknown), Anders Boyd, Liza Coyer, Janke Schinkel, Charles Agyemang, Henrike Galenkamp, Anitra D.M. Koopman, Tjalling Leenstra, Maarten Schim van der Loeff, Eric P. Moll van Charante, Bert‐Jan H. van den Born, Anja Lok, Arnoud P. Verhoeff, Aeilko H. Zwinderman, Suzanne Jurriaans, Karien Stronks, Maria Prins	4
3	SARS-CoV-2 antibody prevalence and correlates of six ethnic groups living in Amsterdam, the Netherlands: a population-based cross-sectional study, June–October 2020 2022 ·BMJ Open ·Liza Coyer, Anders Boyd, Janke Schinkel, Charles Agyemang, Henrike Galenkamp, Anitra D.M. Koopman, Tjalling Leenstra, Eric P. Moll van Charante, Bert‐Jan H. van den Born, Anja Lok, Arnoud P. Verhoeff, Aeilko H. Zwinderman, Suzanne Jurriaans, Lonneke A. van Vught, Karien Stronks, Maria Prins	14
4	Acquisition of wild-type HIV-1 infection in a patient on pre-exposure prophylaxis with high intracellular concentrations of tenofovir diphosphate: a case report 2017 ·The Lancet HIV ·Elske Hoornenborg, Maria Prins, Roel Achterbergh, (unknown), Marion Cornelissen, Suzanne Jurriaans, Neeltje A. Kootstra, Peter L. Anderson, Peter Reiss, Henry J.C. de Vries, Jan M. Prins, Godelieve J. de Bree	54
5	Lactobacillus-dominated cervicovaginal microbiota associated with reduced HIV/STI prevalence and genital HIV viral load in African women 2014 ·The ISME Journal ·Hanneke Borgdorff, Evgeni Tsivtsivadze, Rita Verhelst, Massimo Marzorati, Suzanne Jurriaans, Gilles Ndayisaba, Frank Schuren, Janneke van de Wijgert	203
6	High prevalence of hepatitis B virus dual infection with genotypes A and G in HIV-1 infected men in Amsterdam, the Netherlands, during 2000-2011 2013 ·BMC Infectious Diseases ·Antoinette C. van der Kuyl, Fokla Zorgdrager, Boris M. Hogema, Margreet Bakker, Suzanne Jurriaans, Nicole Back, Ben Berkhout, Hans L. Zaaijer, Marion Cornelissen	14
7	Unusual Cluster of HIV Type 1 Dual Infections in Groningen, The Netherlands 2010 ·AIDS Research and Human Retroviruses ·Antoinette C. van der Kuyl, Suzanne Jurriaans, Nicole Back, Herman G. Sprenger, Tjip S. van der Werf, Fokla Zorgdrager, Ben Berkhout, Marion Cornelissen	8
8	Ongoing HIV-1 transmission among men who have sex with men in Amsterdam: a 25-year prospective cohort study 2010 ·AIDS ·(unknown), Ronald B. Geskus, Udi Davidovich, Suzanne Jurriaans, Roel A. Coutinho, Maria Prins, Ineke G. Stolte	101
9	Steady increase in cellular HIV-1 load during the asymptomatic phase of untreated infection despite stable plasma viremia 2010 ·AIDS ·Alexander Pasternak, Suzanne Jurriaans, Margreet Bakker, Ben Berkhout, Vladimir V. Lukashov	22
10	High Incidence of Asymptomatic Syphilis in HIV-Infected MSM Justifies Routine Screening 2009 ·Sexually Transmitted Diseases ·Judith Branger, Jan T. M. van der Meer, R J van Ketel, Suzanne Jurriaans, Jan M. Prins	74
11	Cellular Levels of HIV Unspliced RNA from Patients on Combination Antiretroviral Therapy with Undetectable Plasma Viremia Predict the Therapy Outcome 2009 ·PLoS ONE ·Alexander Pasternak, Suzanne Jurriaans, Margreet Bakker, Jan M. Prins, Ben Berkhout, Vladimir V. Lukashov	77
12	HIV incidence and HIV testing behavior in men who have sex with men: using three incidence sources, The Netherlands, 1984–2005 2007 ·AIDS ·Nicole H. T. M. Dukers–Muijrers, H Fennema, Eric M. van der Snoek, Anneke Krol, Ronald B. Geskus, (unknown), Suzanne Jurriaans, W I van der Meijden, Roel A. Coutinho, Maria Prins	45
13	Intravenous Immunoglobulin (IVIG) Treatment for Modulation of Immune Activation in Human Immunodeficiency Virus Type 1 Infected Therapy-Naive Individuals 2007 ·AIDS Research and Human Retroviruses ·(unknown), Jan M. Prins, Evelien M. Bunnik, C. Erik Hack, Suzanne Jurriaans, Frank Miedema, Joep M. A. Lange, Hanneke Schuitemaker	8
14	Increase in HCV Incidence among Men Who Have Sex with Men in Amsterdam Most Likely Caused by Sexual Transmission 2007 ·The Journal of Infectious Diseases ·Thijs van de Laar, Akke K. van der Bij, Maria Prins, Sylvia M. Bruisten, Kees Brinkman, (unknown), Jan T. M. van der Meer, Henry J.C. de Vries, Jan‐Willem Mulder, Michiel A. van Agtmael, Suzanne Jurriaans, Katja C. Wolthers, Roel A. Coutinho	218
15	TMC125 exerts similar initial antiviral potency as a five-drug, triple class antiretroviral regimen 2003 ·AIDS ·(unknown), Gerrit Jan Weverling, Monika Peeters, (unknown), (unknown), Aza Rakhmanova, Sven A. Danner, Suzanne Jurriaans, Jan M. Prins, Joep MA Lange	33
16	Penetration of the Nucleoside Analogue Abacavir into the Genital Tract of Men Infected with Human Immunodeficiency Virus Type 1 2001 ·Clinical Infectious Diseases ·Rieneke M. E. van Praag, Rolf P. G. van Heeswijk, Suzanne Jurriaans, Joep M. A. Lange, Richard M. W. Hoetelmans, Jan M. Prins	26
17	Evaluation of a Second-Generation Nucleic Acid Sequence-Based Amplification Assay for Quantification of HIV Type 1 RNA and the Use of Ultrasensitive Protocol Adaptations 2000 ·AIDS Research and Human Retroviruses ·Daan W. Notermans, Frank de Wolf, Peter Oudshoorn, H. Theo M. Cuijpers, Maria Franca Pirillo, (unknown), Daniel McClernon, (unknown), Joep M. A. Lange, Sven A. Danner, Jaap Goudsmit, Suzanne Jurriaans	15
18	Cerebrospinal fluid β2-microglobulin, monocyte chemotactic protein-1, and soluble tumour necrosis factor α receptors before and after treatment with lamivudine plus zidovudine or stavudine 2000 ·Journal of Neuroimmunology ·Roelien H. Enting, Norbert A. Foudraine, Joep M. A. Lange, Suzanne Jurriaans, Tom van der Poll, Gerrit‐Jan Weverling, Peter Portegies	23
19	Evaluation of the World Health Organization staging system for HIV infection and disease in Ethiopia: association between clinical stages and laboratory markers 1999 ·AIDS ·(unknown), Tobias F. Rinke de Wit, Ermias Hailu, (unknown), Tsehaynesh Messele, (unknown), (unknown), Suzanne Jurriaans, Hailu Yeneneh, R A Coutinho, Arnaud Fontanet	61
20	The one-tube quantitative HIV-1 RNA NASBA: precision, accuracy, and application. 1995 ·Genome Research ·Bob van Gemen, (unknown), Rinie van Beuningen, Peter Sillekens, Suzanne Jurriaans, (unknown), (unknown), Tim Kievits	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact